Sativex brain tumour trial backed by Tom Daley starts
Brain tumour researchers hit their funding target after a £400,000 campaign backed by the Olympian. Source link
Brain tumour researchers hit their funding target after a £400,000 campaign backed by the Olympian. Source link
Prof Susan Short, professor of clinical oncology and neuro oncology at the University of Leeds, said: “Even with surgery, radiotherapy and chemotherapy, nearly all of these brain tumours re-grow within a year, and unfortunately there are very few options for patients once this occurs. Source link